Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
November 7, 2025
Company name: Bando Chemical Industries, Ltd. Listing: Tokyo Stock Exchange Securities code: 5195
URL: https://www.bandogrp.com
Representative: Tomio Ueno, President and Representative Director
Inquiries: Kazuyuki Hayashi, Executive Officer and General Manager of Finance and Accounting Department
Telephone: +81-78-304-2516
Scheduled date to file semi-annual securities report: November 10, 2025 Scheduled date to commence dividend payments: December 1, 2025 Preparation of supplementary material on financial results: Yes
Holding of financial results briefing: Yes (for institutional investors and analysts)
(Yen amounts are rounded down to millions, unless otherwise noted.)
-
Consolidated financial results for the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
Revenue
Core operating profit
Operating profit
Profit before tax
Six months ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
September 30, 2025
59,094
1.7
4,463
8.7
6,569
30.1
6,591
45.7
September 30, 2024
58,098
7.7
4,106
9.3
5,048
11.8
4,525
(16.3)
Note: Core operating profit is calculated as revenue subtracted by cost of sales and selling, general, and administrative expenses.
Profit attributable to owners of parent
Total comprehensive income
Basic earnings per share
Diluted earnings per share
Six months ended
Millions of yen
%
Millions of yen
%
Yen
Yen
September 30, 2025
4,819
46.2
6,507
106.9
115.97
-
September 30, 2024
3,297
(10.2)
3,144
(57.5)
77.23
-
- Consolidated financial position
Total assets
Total equity
Equity attributable to owners of parent
Ratio of equity
attributable to owners of parent to total assets
As of
Millions of yen
Millions of yen
Millions of yen
%
September 30, 2025
119,896
86,134
85,895
71.6
March 31, 2025
120,693
82,501
82,131
68.0
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
-
Cash dividends
Annual dividends per share
First quarter-end
Second quarter-end
Third quarter-end
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended
March 31, 2025
-
38.00
-
38.00
76.00
Fiscal year ending March 31, 2026
-
40.00
Fiscal year ending March 31, 2026 (Forecast)
-
40.00
80.00
Note: Revisions to the forecast of cash dividends most recently announced: None
- Consolidated financial results forecast for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)
(Percentages indicate changes from the previous corresponding period.)
Revenue | Core Operating profit | Operating profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen |
117,000 | 1.2 | 8,200 | 5.9 | 10,500 | 201.7 | 7,400 | 394.5 | 178.07 | |
Note: Revisions to the forecast of financial results most recently announced: Yes
* NotesSignificant changes in the scope of consolidation during the period: None
Changes in accounting policies and changes in accounting estimates
Changes in accounting policies required by IFRS: None
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: None
Number of issued shares (ordinary shares)
Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2025
44,213,536 shares
As of March 31, 2025
44,213,536 shares
Number of treasury shares at the end of the period
As of September 30, 2025
3,045,683 shares
As of March 31, 2025
2,410,402 shares
Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2025 | 41,556,033 shares |
Six months ended September 30, 2024 | 42,697,892 shares |
Note: The Company has introduced an executive compensation BIP trust. Shares of the Company owned by the trust are included in the treasury shares.
Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm.
Proper use of earnings forecasts, and other special matters
Forward-looking statements contained in this document, including financial results forecasts, are based on information currently available to the Company and certain assumptions that the Company believes to be
reasonable. The Company makes no assurances as to the actual results and/or other outcomes, which may differ significantly from these forecasts due to various factors. Please refer to page 3, "1. Qualitative information on Financial Results for the Six Months ended September 30, 2025 (4) Explanation of Consolidated Financial Results Forecast" for the suppositions that form the assumptions used for and the use of the financial results forecasts.
The Company plans to hold a briefing session for institutional investors and analysts on November 20, 2025. Immediately after the meeting, the presentation materials will be available on the Company's website.
Table of Contents
Qualitative information on Financial Results for the Six Months ended September 30, 2025 2
Explanation of Operating Results 2
Explanation of Financial Position 3
Explanation of Cash Flows 3
Explanation of Consolidated Financial Results Forecast 3
Condensed Interim Consolidated Financial Statements and Significant Notes 4
Condensed Interim Consolidated Statement of Financial Position 4
Condensed Interim Consolidated Statements of Income and Comprehensive Income 6
Condensed Interim Consolidated Statement of Changes in Equity 8
Condensed Interim Consolidated Statement of Cash Flows 9
Notes to the Condensed Interim Consolidated Financial Statements 11
(Going Concern Assumption) 11
(Segment Information) 11
-
Qualitative Information on Financial Results for the Six Months ended September 30, 2025
Explanation of Operating Results
Six Months ended September 30, 2024 (Millions of yen)
Six Months ended September 30, 2025 (Millions of yen)
Change
(Millions of yen)
Change in ratio (%)
Revenue
58,098
59,094
995
1.7
Automotive Parts
29,257
29,481
223
0.8
Industrial Products
19,267
19,731
463
2.4
Advanced Elastomer Products
7,070
7,118
48
0.7
Other
2,917
3,151
233
8.0
Adjustments
(414)
(389)
25
-
Core operating profit (loss) (Segment profit (loss))
4,106
4,463
356
8.7
Automotive Parts
2,470
2,432
(38)
(1.6)
Industrial Products
1,348
1,672
323
24.0
Advanced Elastomer Products
(11)
140
152
-
Other
164
81
(82)
(50.1)
Adjustments
134
136
1
1.1
Operating profit
5,048
6,569
1,521
30.1
Profit before tax
4,525
6,591
2,066
45.7
Profit attributable to owners of parent
3,297
4,819
1,521
46.2
Note: Core operating profit is calculated as revenue subtracted by cost of sales and selling, general, and administrative expenses.
Revenue for the six months ended September 30, 2025 increased by 1.7% to ¥59,094 million compared with the same period of the previous fiscal year, core operating profit increased by 8.7% to ¥4,463 million, operating profit increased by 30.1% to ¥6,569 million, profit before tax increased by 45.7% to 6,591 million, and profit attributable to owners of parent increased by 46.2% to ¥4,819 million.
The operating results for the six months ended September 30, 2025 by business segment were as follows:
Automotive Parts
In Japan, although automobile production volume decreased, sales of accessory drive power transmission belts (such as RIBACE™) increased due to an increase in the number of models adopting to the Company's products. Overseas, sales of products for aftermarket industries increased in the U.S. and Europe. Sales of variable speed belts for scooters increased as production by motorcycle manufacturers was trending steadily upward in China. Although sales of variable speed belts for scooters for aftermarket industries increased, sales of accessory drive power transmission system goods (such as Auto Tensioner) decreased in Asia.
As a result, revenue increased by 0.8% to ¥29,481 million compared with the same period of the previous fiscal year. On the other hand, segment profit decreased by 1.6% to ¥2,432 million compared with the same period of the previous fiscal year due to changes in sales mix.
Industrial Products
Regarding industrial power transmission belts, sales of power transmission belts for industrial machinery shifted the same level as the previous year in Japan. Overseas, sales of power transmission belts for industrial machinery increased in the U.S. and Europe, sales of power transmission belts for agricultural machinery increased in China. Sales of power transmission belts for agricultural machinery decreased in Asia.
For conveyor belts, sales of heavy-duty conveyor belts and light-duty conveyor belts (such as SUNLINE™ belt) increased in Japan.
As a result, revenue increased by 2.4% to ¥19,731 million compared with the same period of the previous fiscal year. On the other hand, segment profit increased by 24.0% to ¥1,672 million compared with the same period of the previous fiscal year.
Advanced Elastomer Products
Regarding films products, sales of decorative display films increased.
For precision parts, sales of precision belts and cleaning blades decreased, although sales of high-performance rollers increased.
As a result, revenue increased by 0.7% to ¥7,118 million compared with the same period of the previous fiscal year. Segment profit was ¥140 million compared with ¥11 million of segment loss for the same period of the previous fiscal year.
Other
Other segment includes the robotics-related devices, electronic products, and medical equipment businesses. Revenue increased by 8.0% to ¥3,151 million and segment profit decreased by 50.1% to ¥81 million compared with the same period of the previous fiscal year.
The above revenue and profit by segment were the amount before the elimination of intersegment transactions.
Explanation of Financial Position
Total assets as of September 30, 2025 decreased by ¥797 million to ¥119,896 million compared with the end of the previous fiscal year. The main reason was a decrease in cash and cash equivalents, income taxes receivable, and investment accounted for using equity method while trade and other receivables increased.
Total liabilities decreased by ¥4,430 million to ¥33,761 million compared with the end of the previous fiscal year. The main reason was a decrease in borrowings.
Total equity increased by ¥3,633 million to ¥86,134 million compared with the end of the previous fiscal year. The main reason was an increase in retained earnings while the Company acquired treasury shares.
As a result, the ratio of equity attributable to owners of parent to total assets was 71.6%, compared with 68.0% at the end of the previous fiscal year.
Explanation of Cash Flows
Cash and cash equivalents as of September 30, 2025 decreased by ¥1,342 million to ¥16,373 million compared with the beginning of the fiscal year. The summary of cash flows and major factors were as follows:
(Cash flows from operating activities)
Net cash provided by operating activities increased by ¥2,734 million to ¥8,345 million compared with the same period of the previous fiscal year. The main reason was an increase in proceeds from operations after adjusting profit before tax for non-cash items.
(Cash flows from investing activities)
Net cash used in investing activities decreased by ¥1,391 million to ¥1,175 million compared with the same period of the previous fiscal year. The main reasons were proceeds from withdrawals of term deposits exceeded payments into term deposits and an increase in proceeds from sale of equity instruments.
(Cash flows from financing activities)
Net cash used in financing activities increased by ¥4,156 million to ¥8,618 million compared with the same period of the previous fiscal year. The main reason was an increase in repayments of borrowings.
Explanation of Consolidated Financial Results Forecast
The Company has revised its consolidated financial results forecast for the fiscal year ending March 31, 2026, which was announced on May 15, 2025, in light of the financial results for the six months ended September 30, 2025 and outlook for the future.
For more details, please refer to the "Notice Concerning Revisions to Consolidated Financial Results Forecast for the Fiscal Year" which has been announced today.
- Condensed Interim Consolidated Financial Statements and Significant Notes
Condensed Interim Consolidated Statement of Financial Position
(Millions of yen)
Assets
Current assets
As of March 31, 2025 As of September 30, 2025
Cash and cash equivalents
17,715
16,373
Trade and other receivables
22,978
24,068
Inventories
19,530
19,345
Income taxes receivable
380
76
Other financial assets
1,530
652
Other current assets
1,259
1,371
Total current assets
63,396
61,888
Non-current assets
Property, plant and equipment
30,532
30,607
Goodwill
1,175
1,179
Intangible assets
2,748
2,592
Investments accounted for using equity method
11,590
11,315
Other financial assets
10,318
11,385
Deferred tax assets
647
654
Other non-current assets
283
272
Total non-current assets
57,297
58,007
Total assets
120,693
119,896
Liabilities and equity Liabilities
Current liabilities
(Millions of yen) As of March 31, 2025 As of September 30, 2025
Trade and other payables
18,098
17,745
Borrowings
5,350
483
Income taxes payable
764
1,479
Other financial liabilities
1,064
1,118
Provisions
1
0
Other current liabilities
6,013
6,205
Total current liabilities
31,292
27,033
Non-current liabilities
Borrowings
1,787
1,562
Retirement benefit liability
880
913
Other financial liabilities
1,649
1,730
Deferred tax liabilities
1,895
2,021
Other non-current liabilities
686
500
Total non-current liabilities
6,899
6,728
Total liabilities
38,191
33,761
Equity
Share capital
10,951
10,951
Capital surplus
2,921
2,939
Retained earnings
59,418
62,819
Treasury shares
△3,678
△4,845
Other components of equity
12,519
14,029
Total equity attributable to owners of parent
82,131
85,895
Non-controlling interests
369
239
Total equity
82,501
86,134
Liabilities and equity
120,693
119,896
Condensed Interim Consolidated Statements of Income and Comprehensive Income (Condensed Interim Consolidated Statement of Income)
Six months ended September 30, 2024
(Millions of yen)
Six months ended September 30, 2025
Revenue
58,098
59,094
Cost of sales
41,732
41,888
Gross profit
16,366
17,206
Selling, general and administrative expenses
12,259
12,742
Other income
402
1,693
Other expenses
260
232
Share of profit of investments accounted for using equity method
799
645
Operating profit
5,048
6,569
Finance income
259
282
Finance costs
781
260
Profit before tax
4,525
6,591
Income tax expenses
1,201
1,758
Profit
3,323
4,832
Profit attributable to
Owners of parent
3,297
4,819
Non-controlling interests
26
13
Profit
3,323
4,832
Earnings per share
Basic earnings per share (Yen) 77.23 115.97
(Condensed Interim Consolidated Statement of Comprehensive Income)
(Millions of yen)
Six months ended
Six months ended
September 30, 2024
September 30, 2025
Profit
3,323
4,832
Other comprehensive income
Items that will not be reclassified to profit or loss Net change in fair value of equity instruments
designated as measured at fair value through
(220)
980
other comprehensive income
Share of other comprehensive income of investments accounted for using equity
(8)
4
method
Total
(228)
984
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
Share of other comprehensive income of
(11) 608
investments accounted for using
method
equity
62
81
Total
50
690
Total other comprehensive income
(178)
1,674
Comprehensive income
3,144
6,507
Comprehensive income attributable to Owners of parent
3,134
6,500
Non-controlling interests
10
7
Comprehensive income
3,144
6,507
Condensed Interim Consolidated Statement of Changes in Equity
Six months ended September 30, 2024
Equity attributable to owners of parent
Total equity
Non-
(Millions of yen)
Share capital
Capital surplus
Retained earnings
Treasury shares
Other component s of equity
attributable to owners of parent
controlling interests
Total
Balance as of April 1, 2024
10,951
2,936
61,039
(1,692)
11,927
85,163
347
85,511
Profit
3,297
3,297
26
3,323
Other comprehensive income
(162)
(162)
(16)
(178)
Total comprehensive income
-
-
3,297
-
(162)
3,134
10
3,144
Dividends of surplus
(1,630)
(1,630)
(21)
(1,651)
Purchase of treasury shares
(982)
(982)
(982)
Disposal of treasury shares
1
14
15
15
Share-based remuneration transactions
14
14
14
Total transactions with the owners
-
16
(1,630)
(967)
-
(2,582)
(21)
(2,603)
Balance as of September 30, 2024
10,951
2,952
62,706
(2,660)
11,765
85,716
336
86,052
Six months ended September 30, 2025
(Mill
ions of yen)
Equity attributable to owners of parent
Total equity
Non-
Share capital
Capital surplus
Retained earnings
Treasury shares
Other component s of equity
attributable to owners of parent
controlling interests
Total
Balance as of April 1, 2025
10,951
2,921
59,418
(3,678)
12,519
82,131
369
82,501
Profit
4,819
4,819
13
4,832
Other comprehensive income
1,681
1,681
(6)
1,674
Total comprehensive income
-
-
4,819
-
1,681
6,500
7
6,507
Dividends of surplus
(1,588)
(1,588)
(137)
(1,725)
Purchase of treasury shares
(1,181)
(1,181)
(1,181)
Disposal of treasury shares
2
15
17
17
Share-based remuneration transactions
14
14
14
Transfer from other components of equity to
retained earnings
170
(170)
-
-
Total transactions with the owners
-
17
(1,418)
(1,166)
(170)
(2,737)
(137)
(2,874)
Balance as of September 30, 2025
10,951
2,939
62,819
(4,845)
14,029
85,895
239
86,134
Condensed Interim Statement of Cash Flows
(Millions of yen)
Six months ended
Six months ended
September 30, 2024
September 30, 2025
Cash flows from operating activities
Profit before tax
4,525
6,591
Depreciation and amortization
2,975
2,655
Impairment losses
53
64
Interest and dividend income
(246)
(270)
Interest expenses
45
49
Foreign exchange loss (gain)
439
61
Share of loss (profit) of investments accounted for using equity method
(799) (645)
Loss (gain) on sale and retirement of fixed assets 21 29
Decrease (increase) in inventories 610 407
Decrease (increase) in trade and other
receivables
(346)
(977)
Increase (decrease) in trade and other payables
(1,017)
126
Increase (decrease) in retirement benefit liability
25
34
Increase (decrease) in provisions
1
(0)
Increase / decrease in other current liabilities
(248)
131
Increase / decrease in other non-current liabilities
(210)
(188)
Other
(167)
103
Subtotal
5,662
8,173
Interest and dividends received
1,535
1,290
Interest paid
(44)
(50)
Income taxes paid
(1,742)
(1,406)
Income taxes refund
199
338
Net cash provided by (used in) operating activities
5,610
8,345
Cash flows from investing activities
Payments into time deposits
(1,833)
(627)
Proceeds from withdrawal of time deposits
1,739
1,520
Purchase of property, plant and equipment
(2,392)
(2,322)
Proceeds from sale of property, plant and equipment
6
13
Purchase of intangible assets
(107)
(126)
Proceeds from sale of equity instruments
-
334
Other
20
32
Net cash provided by (used in) investing activities
(2,567)
(1,175)
Cash flows from financing activities
Six months ended September 30, 2024
(Millions of yen)
Six months ended September 30, 2025
Net increase (decrease) in short-term loans
borrowings (within three months)
(400)
(4,866)
Repayments of long-term borrowings
(825)
(225)
Repayments of lease liabilities
(602)
(619)
Purchase of treasury shares
(982)
(1,181)
Dividends paid to owners of parent
(1,630)
(1,588)
Dividends paid to non-controlling interests
(21)
(137)
Net cash provided by (used in) financing activities
(4,462)
(8,618)
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
(39) 106
(1,458) (1,342)
Cash and cash equivalents at beginning of period 17,935 17,715
Cash and cash equivalents at end of period 16,477 16,373
Notes to the Condensed Interim Consolidated Financial Statements (Going Concern Assumption)
None
(Segment Information)
Summary of reportable segments
The reportable segments are components of the Company for which separate financial information is available and whose operating results are reviewed by the Board of Directors to allocate resources and assess segment performance.
The Group comprises operating divisions based on products and services, and each operating division develops a comprehensive strategy for respective products and services for domestic and overseas markets and conducts business activities.
Therefore, the Group's business consists of three reportable segments categorized by products and services based on operating division of the parent company: "Automotive Parts Business," "Industrial Products Business," and "Advanced Elastomer Products Business."
The main products by reportable segment are as follows:
Segment name
Main products
Automotive Parts Business
Automotive power transmission belt products (accessory drive power transmission belts and system goods), power transmission belt products for motorcycles (variable speed belts for scooters), etc.
Industrial Products Business
Industrial power transmission belt products (Industrial machinery V-belts, synchronous belts, pulleys, etc.), other power transmission products, conveyor belts (heavy-duty conveyor belts, light-duty conveyor belts, synchronous conveyance belts, etc.), conveyor system goods, rice hulling rolls, etc.
Advanced Elastomer Products Business
Cleaning blades, high-performance rollers, precision belts, polyurethane functional parts, precision polishing materials, films for construction materials, medical films, decorative display films, industrial films, etc.
Information on revenue, profit or loss, and other items by reportable segments Intersegment revenue is based on market prices.
Revenue, profit or loss, and other items by reportable segments are as follows:
Six months ended September 30, 2024 (Millions of yen)
Reportable Segment | Other (Note 1) | Adjustments (Note 2) | Consolidated (Note 3) | ||||
Automotive Parts | Industrial Products | Advanced Elastomer Products | Total | ||||
Revenue | |||||||
Revenue from external customers | 29,257 | 19,264 | 7,070 | 55,593 | 2,505 | - | 58,098 |
Intersegment revenue | - | 2 | 0 | 2 | 412 | (414) | - |
Total | 29,257 | 19,267 | 7,070 | 55,595 | 2,917 | (414) | 58,098 |
Segment profit (loss) (Core operating profit (loss)) | 2,470 | 1,348 | (11) | 3,807 | 164 | 134 | 4,106 |
Other income | - | - | - | - | - | - | 402 |
Other expenses | - | - | - | - | - | - | 260 |
Share of profit of investments accounted for using equity method | - | - | - | - | - | - | 799 |
Operating profit | - | - | - | - | - | - | 5,048 |
Finance income | - | - | - | - | - | - | 259 |
Finance costs | - | - | - | - | - | - | 781 |
Profit before tax | - | - | - | - | - | - | 4,525 |
Notes:
The Other segment comprises businesses that are not included in any reportable segments. It mainly includes the medical equipment and robotics-related devices businesses.
Adjustments of segment profit (loss) of ¥134 million include the elimination of intersegment transactions of ¥19 million and corporate expenses of ¥115 million. Corporate expenses are differences between the estimated allocation of general administrative expenses and research and development expenses to each reportable segment and the actual amount incurred.
The Group uses core operating profit, calculated as revenue subtracted by cost of sales and selling, general and administrative expenses, as a key indicator for business management. Segment profit (loss) is based on core operating profit.
Six months ended September 30, 2025 (Millions of yen)
Reportable Segment | Other (Note 1) | Adjustments (Note 2) | Consolidated (Note 3) | ||||
Automotive Parts | Industrial Products | Advanced Elastomer Products | Total | ||||
Revenue | |||||||
Revenue from external customers | 29,481 | 19,731 | 7,115 | 56,328 | 2,765 | - | 59,094 |
Intersegment revenue | - | - | 3 | 3 | 385 | (389) | - |
Total | 29,481 | 19,731 | 7,118 | 56,332 | 3,151 | (389) | 59,094 |
Segment profit (loss) (Core operating profit (loss)) | 2,432 | 1,672 | 140 | 4,244 | 81 | 136 | 4,463 |
Other income | - | - | - | - | - | - | 1,693 |
Other expenses | - | - | - | - | - | - | 232 |
Share of profit of investments accounted for using equity method | - | - | - | - | - | - | 645 |
Operating profit | - | - | - | - | - | - | 6,569 |
Finance income | - | - | - | - | - | - | 282 |
Finance costs | - | - | - | - | - | - | 260 |
Profit before tax | - | - | - | - | - | - | 6,591 |
Notes:
The Other segment comprises businesses that are not included in any reportable segments. It mainly includes the medical equipment and robotics-related devices businesses.
Adjustments of segment profit (loss) of ¥136 million include the elimination of intersegment transactions of ¥18 million and corporate expenses of ¥117 million. Corporate expenses are differences between the estimated allocation of general administrative expenses and research and development expenses to each reportable segment and the actual amount incurred.
The Group uses core operating profit, calculated as revenue subtracted by cost of sales and selling, general and administrative expenses, as a key indicator for business management. Segment profit (loss) is based on core operating profit.
